Prescription drug · UNAPPROVED DRUG OTHER
Effer-K Lemon Citrus (potassium bicarbonate) NDC 51801-005
Potassium bicarbonate 977.5 mg/1 · Tablet, Effervescent · Oral · Nomax Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51801-005-30 | 51801000530 | 30 POUCH in 1 CARTON (51801-005-30) / 1 TABLET, EFFERVESCENT in 1 POUCHMarketed from Jan 30, 2013 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Effer-K Lemon CitrusSuffix: Lemon Citrus
- Generic name (nonproprietary)
- potassium bicarbonate
- Active ingredients
- Potassium bicarbonate — 977.5 mg/1
- Dosage form
- Tablet, Effervescent
- Route
- Oral
- Labeler
- Nomax Inc.
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 51801-005_de8efd5c-a055-462d-a104-5bca4773fe0cSPL ID de8efd5c-a055-462d-a104-5bca4773fe0cSPL set ID bd402d91-d28d-49e9-9c1d-0983854773b3RxCUI 1088772, 1088774UNII HM5Z15LEBN
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451801000530followed by a unit qualifier and the quantityPackage 51801-0005-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Indications and Usage For therapeutic use in patients with hypokalemia with or without metabolic alkalosis; in chronic digitalis intoxication; and in patients with hypokalemic familial periodic paralysis. For prevention of potassium depletion when the dietary intake of potassium ion is inadequate in the following conditions; patients receiving digitalis and diuretics for congestive heart failure; hepatic cirrhosis with ascites; states of aldosterone excess with normal renal function; potassiumlosing nephropathy, and certain diarrheal states; long-term corticosteroid therapy. The use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension or receiving certa…
Excerpt only. Read the full label for complete information.